Table 2 Distribution of miR-1260a, and miR-1260b expression levels in patients with ovarian cancer
From: High expression level of miR-1260 family in the peripheral blood of patients with ovarian carcinoma
Diagnosis | miR-1260a Expression | Total | miR-1260b Expression | Total | ||
|---|---|---|---|---|---|---|
Increased n(%) | Decreased n(%) | Total n (%) | Increased n(%) | Decreased n(%) | Total n (%) | |
Patients with Only Ovarian Cancer | 66(64.1%) | 37(35.9%) | 103(81.1%) | 74(71.8%) | 29(28.2%) | 103(81.1%) |
Patients Diagnosed With both Ovarian and Breast Cancer | 10(62.5%) | 6(37.5%) | 16(12.6%) | 12(75.0%) | 4(25.0%) | 16(12.6%) |
Patients with both Ovarian and Endometrial Cancer | 1 (50.0%) | 1(50.0%) | 2(1.6%) | 1 (50.0%) | 1(50.0%) | 2(1.6%) |
Patients with Ovarian and Other Cancers | 6(100.0%) | 0(00.0%) | 6(4.7%) | 6(100.0%) | 0(0.0%) | 6(4.7%) |
Total n (%) | 83(65.3%) | 44(34.7%) | 127 | 93(73.2%) | 34(26.8%) | 127 |